Very low birth weight (VLBW) preterm infants (<1.5 kg) require up to four times more protein and energy than human milk alone provides. Without adequate fortification, they face poor weight gain and lifelong neurodevelopmental disorders. About 1.5–2% of all newborns fall into this category and need protein-enriched nutrition daily for 2–3 months.
We are developing the BABYLAT Enricher—a novel, automated device that enables hospitals to concentrate the protein and fat fraction from human milk (mother own milk or donor milk) directly on-site. Our proprietary bedside technology allows fast, efficient extraction of human milk protein. No comparable automated solution currently exists on the market. We plan to sell the device and daily filter consumables to large perinatal centers with NICUs.
19.01.2026
Babylat secures bi-lateral grant and advances into the clinical stage (startupticker.ch)
07.10.2025
Venture Leaders Medtech Roadshow 2025: Swiss Medtech startups shine in Boston (venturelab.swiss)
15.09.2025
Babylat: The Venture Leader Medtech improving preterm neonatal care with on-site milk fortifiers (venturelab.swiss)
19.08.2025
Venture Leaders Medtech 2025 kick-off their Boston roadshow (venturelab.swiss)
09.07.2025
Ten Medtech startups to explore US expansion opportunities (startupticker.ch)
01.11.2025
Swiss-Polish grant approved
No Jobs
Venture Kick supports potential entrepreneurs with start capital up to CHF 150'000 as well as hands-on execution support and access to a nationwide network of investors and experts in the startup field. Multiple times per year, 8 selected projects get the opportunity to present their business ideas in front of a panel. The 5 most promising projects enter the support process. After 9 months at the latest, the startups incorporate and enter the market. Since 2007, Venture Kick has invested over CHF 58 million in over 1111 projects.
Website:
www.babylat.com
Headquarter:
Bern
Foundation Date:
October 2020
Technology:
Sectors: